Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Schrodinger Inc
(NQ:
SDGR
)
22.40
+0.84 (+3.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 12, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Schrodinger Inc
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
What Analysts Are Saying About Schrodinger Stock
July 11, 2024
Via
Benzinga
Simulations Plus Stock Drops 15% Despite EPS Beat
July 05, 2024
Simulations Plus fell 15% the day after its earnings release despite beating EPS estimates due to lower margins and lower full-year guidance.
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Top-Rated Gene Editing Stocks Actually Making Money
July 03, 2024
Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond.
Via
InvestorPlace
Largest Clinical-Stage BioTech Drug Stocks Declined 6%
June 22, 2024
Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they...
Via
Talk Markets
AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th
June 17, 2024
The global
Via
Talk Markets
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 14, 2024
From
Schrödinger
Via
Business Wire
AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week
June 10, 2024
The global
Via
Talk Markets
The 7 AI Categories Were Down 4%, On Average, This Week; Up 1% In May
June 01, 2024
The 7 AI categories we track dropped, down 4.3% this week, and are now only up 1.3% for the month of May.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Schrödinger to Present at Jefferies Global Healthcare Conference
May 22, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024
From
Schrödinger
Via
Business Wire
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
May 16, 2024
AI continues to impact pharma stocks to buy in a major way, with these shares particularly well positioned as things heat up.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
What's the Difference Between Biotech Stocks and TechBio Stocks?
May 15, 2024
A few enterprising businesses are marketing themselves differently.
Via
The Motley Fool
Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week
May 13, 2024
Via
Talk Markets
The 7 AI Categories Declined, On Average, The First Week Of May
May 05, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May
May 05, 2024
We look at the performance of 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies during the first week of May and YTD.
Via
Talk Markets
Etsy Reports Downbeat Earnings, Joins Fastly, DoorDash And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
May 02, 2024
Via
Benzinga
SDGR Stock Earnings: Schrodinger Misses EPS, Misses Revenue for Q1 2024
May 01, 2024
SDGR stock results show that Schrodinger missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 01, 2024
Via
Benzinga
Schrödinger Reports First Quarter 2024 Financial Results
May 01, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
April 18, 2024
From
Schrödinger
Via
Business Wire
The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD
April 15, 2024
The pharmaceutical industry is embracing AI to streamline drug discovery and researching the use of psychedelic compound-based ingredients for the treatment of, as yet, untreatable diseases.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Schrödinger to Announce First Quarter 2024 Financial Results on May 1
April 10, 2024
From
Schrödinger
Via
Business Wire
5 Healthcare Stocks to Buy for 2024
April 02, 2024
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Invest Like Bill Gates With These 3 AI Stocks to Buy
March 27, 2024
Bill Gates is undoubtedly interested in AI stocks to buy. Here are three of his foundation’s current holdings.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Shhh! 7 Small-Cap Stocks That Can Double by 2025
March 20, 2024
Small-cap stocks have been hot and these shares discussed here are likely to heat up and double over the next year.
Via
InvestorPlace
Schrödinger Highlights Discovery of SGR-1505, Clinical-Stage MALT1 Inhibitor, at American Chemical Society National Meeting
March 20, 2024
From
Schrödinger
Via
Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 19, 2024
From
Schrödinger
Via
Business Wire
Billionaire Bill Gates Has 35% of His Portfolio Invested in These 2 Artificial Intelligence (AI) Stocks: Are They No-Brainer Buys?
March 18, 2024
AI is a key growth driver for both of these stocks owned by the Gates Foundation Trust.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
10 Health Care Stocks Whale Activity In Today's Session
March 04, 2024
Via
Benzinga
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
March 04, 2024
Grand View Research says the global
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.